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A second arterial conduit to the circumflex circulation significantly improves survival after coronary artery bypass surgery 
INTRODUCTION
Arterial conduits have better patency rates and have been associated with a survival benefit in surgical revascularization. The left internal mammary artery (LIMA) grafted to the left anterior descending (LAD) artery offers well-established, long-term survival benefits [1] . Previous non-randomized studies have demonstrated the benefits to long-term survival of using 2 or more arterial grafts, especially bilateral internal mammary arteries. Fewer than 10-15% of coronary artery bypass grafts (CABGs) are performed with an additional arterial graft to the left-sided circulation. An 80% rate of multiarterial grafting has been estimated to prevent more than 10 000 deaths annually and add >64 000 person-years of life over the course of 10 years [2] . Further, studies of multiarterial and total arterial revascularization have failed to establish an early survival benefit of arterial grafts, despite superior proclaimed patency rates for arterial grafts.
The aim of this study was to assess the early and late survival benefits of an additional arterial graft, as opposed to a venous graft, to the circumflex circulation. A secondary aim was to compare survival differences between various arterial grafts to the circumflex circulation in double-or triple-vessel coronary artery disease.
METHODS
Data for isolated CABG surgical procedures were collected retrospectively from October 2004 to March 2014 from the New Cross Hospital database (PATS, Dendrite Clinical Systems Ltd, Henley-on-Thames, UK). Inclusion criteria were (i) an internal mammary artery to the LAD artery, (ii) double-or triple-vessel disease and (iii) at least 1 additional conduit (venous or arterial) to the circumflex circulation in addition to an internal mammary artery graft to the LAD artery. Patients with a venous graft to the LAD system, single-vessel disease and other concomitant procedures were excluded. Patients with at least 1 additional arterial graft to the circumflex territory were included in the arterial group irrespective of the other grafts to that territory. The hospital database is reviewed, audited and validated monthly by audit officers and linked to the national database, the National Institute for Cardiovascular Outcomes Research (UK). Survival was updated from the Office of National Statistics through the National Health Service number up to September 2014. Hospital data were 99.8% complete. In-hospital mortality data were 100% complete, but long-term survival data linked through the Office of National Statistics could not be tracked in 2.3% of the patients. These patients were censured from long-term survival analysis after discharge or in-hospital death (Fig. 1) . Approval was obtained from the hospital review committee. Consent for individual use of data was waived due to the nature of the study and prior approval for use of such data obtained at the time of consent for the operation.
Surgical technique
Various grafting techniques were used. These included conventional CABG with LIMA grafts to the LAD artery and saphenous vein (SV) grafts to other territories, use of radial arteries in combination with or as an alternative to the SV, various LIMA-right internal mammary artery (RIMA) configurations including free RIMA, Y grafts and in situ IMAs to the LAD circumflex or right coronary territories.
Data analysis
Baseline demographic characteristics for CABG were stratified for those with at least 1 arterial conduit or all venous conduits to the circumflex territory in addition to an arterial graft (left or right internal thoracic artery) to the LAD system. Continuous variables were compared using the Mann-Whitney test, and categorical variables were compared using the v 2 test. A P-value of < _0.05 was considered significant. All statistical analyses were performed using Stata Version 13.1 (College Station, TX, USA).
Propensity score matching
Propensity matching was used to balance the confounders in this non-randomized, observational study. The following confounders were included in the propensity match: age, logistic European System for Cardiac Operative Risk Evaluation score (EuroSCORE), body mass index, gender, 3-vessel disease, pulmonary disease, neurological disease, renal disease, hypertension, left main stem disease, diabetes, left ventricular ejection fraction, New York Heart Association (NYHA) functional class, previous percutaneous coronary interventions and previous myocardial infarction. The definitions used for these risk factors were those previously described for the calculation of the EuroSCORE by Roques et al. [3, 4] .
The propensity score was estimated by logistic regression. Patients treated with an arterial conduit were posteriorly matched to those with a venous conduit in a 1:1 ratio using the nearest-neighbour method without replacement with a calipre width of 0.2 of the standard deviation of the propensity score logit. Means, standard deviations and proportions of baseline demographic characteristics were compared to assure appropriate balance among groups; statistical significance was tested using a Wilcoxon signed-rank paired test and the McNemar's test for continuous and categorical variables, respectively. In addition, balance was compared by percent bias (standardized difference), considering an appropriate balance when bias <10%.
Hazard functions and survival analysis
Postoperative survival was plotted using the Kaplan-Meier functions, and the equality of survivor functions was tested using a log-rank test. The log-rank testing was stratified by the matched pairs in the propensity-matched cohort. For fixed-time survival, a Bonferroni adjustment was made to correct for multiple testing (total number of cross-sectional tests: 7), and unadjusted P-value of <0.007 was deemed statistically significant. To analyse the association of covariates on overall survival among the propensity-matched cohorts, each confounder was tested using a Cox proportional hazards model. All confounders with a P-value of < _0.2 were included in the multivariable model, and the proportionality assumption was tested using Schoenfeld residuals. Hazard ratios (HRs) were estimated for each variable.
Outcomes
The in-hospital mortality rate (deaths within 30 days or during the same admission as the operation) was compared using the v 2 test in unmatched patients and the McNemar's test in those who were matched. Overall, early (within 5 years) and late (after 5 years) survival was compared using a log-rank test. Subgroup survival analysis was performed for patients aged >70 years or < _70 years and by the number of arterial conduits used during CABG and compared using log-rank testing.
RESULTS
A total of 3995 patients who had isolated, first-time CABG between October 2004 and March 2014 were included. All patients had either a left or a right internal thoracic artery to the LAD system and at least 1 or more conduits to the circumflex circulation. The mean follow-up period was 64.5 months (venous) vs 74.5 months (arterial). Among these, 2757 patients had only venous conduits to the circumflex circulation, and 1238 patients had at least 1 arterial conduit (an internal thoracic artery or a radial artery) to this circulation. The baseline demographics and operative characteristics are shown in Tables 1 and 2 .
The number of survivors at 1, 3, 5, 7 and 10 years in unmatched and matched data and survival curves are shown in Fig. 2 .
Unmatched cohorts
Early and mid-term survival (up to 5 years). The inhospital mortality rate was 1.12% (arterial) vs 1.24% (venous) (P = 0.773). The survival differences continued to improve in favour of arterial conduits from the 2nd year onwards (96.1%, venous vs 97.4%, arterial; P = 0.046). These differences were, however, statistically not significant after the Bonferroni correction for multiple testing (threshold for significance P < 0.007).
Late survival (after 5 years). The overall 10-year survival rate was 74.6% (venous) vs 82.6% (arterial) (P = 0.001). The survival differences continued to improve in favour of arterial grafts for up to 10 years.
Propensity-matched cohort
A total of 1226 patients with a second arterial conduit (second conduit to the circumflex territory after LIMA to the LAD artery) were matched to 1226 patients with a second venous conduit. The demographic and procedural characteristics of the matched cohorts are given in Table 3 .
Multivariable analysis. The Cox proportional hazards regression analysis in the propensity-matched cohorts identified a second arterial conduit, the logistic EuroSCORE, treated diabetes, left ventricular ejection fraction <30%, NYHA Class III-IV and previous myocardial infarction as significant predictors of survival ( Table 4 ). The c-statistic for the Cox proportional hazards model was 0.71, and Schoenfeld testing failed to reject proportionality (P = 0.617). A second arterial graft to the left circumflex circulation as opposed to a venous graft was a predictor of improved survival [ Table 4 , univariable: HR 0.45, 95% confidence interval Early and mid-term survival (up to 5 years). The inhospital survival rate in matched patients was 99.2% (arterial) vs 98.8% (venous) (P = 0.29). After adjusting for multiple testing, the survival differences were significant in propensity-matched groups from the 3rd year (93.4% vs 96.1%, P = 0.005). These differences continued to improve in favour of arterial conduits, more so than in the unmatched groups, for up to 5 years of midterm follow-up.
Late survival (after 5 years). The overall matched 10-year survival rate was 64.1% (venous) vs 82.2% (arterial) (P < 0.001).
There were 122 and 166 deaths in the arterial and venous cohorts, respectively (overall log rank P < 0.001). The late survival benefit was incremental in favour of the arterial grafts because the survival curves continued to diverge. There was a sharper divergence between the survival curves at 5 years in the propensity-matched cohorts due to an accelerated decline in survival in the venous group (Fig. 2) . The year-on-year late incremental differences in the propensity-matched cohorts in favour of arterial grafts were superior to those in the unmatched groups. 
Comparison of conduits to the circumflex circulation
All second arterial conduits to the circumflex circulation improved the survival rate compared with the venous conduits (Fig.  3) . A comparison of the arterial conduits showed that internal mammary arteries conferred better survival than radial arteries at 10 years. LIMA was superior to RIMA (97.5% vs 94%, P = 0.374), and RIMA was superior to the radial artery as a second conduit (94% vs 88.8%, P = 0.219), although these differences were not significant.
Comparison of survival by age
When patients were stratified by age, both populations aged greater than 70 years (P = 0.016) and less than or equal to 70 years (P = 0.019) had a significantly increased overall survival rate with the use of an additional arterial conduit to the left-sided circulation (see Supplementary Material, Fig. S1 ). This difference was most pronounced in the propensity-matched cohorts with an early survival difference in both age groups (P < 0.001).
Number of arterial conduits and survival
In propensity-matched patients, the addition of a single additional arterial conduit to the left-sided circulation improved the survival rate (1 vs 2 conduits, P = 0.049) (Fig. 4) . There was no improvement in the survival rate with the use of additional arterial conduits to the circumflex circulation in the matched cohort (2 vs > _3 conduits, P = 0.906).
COMMENT
There is consensus that grafting the LIMA to the LAD offers a long-term survival benefit. Evidence is also clear that using 2 internal thoracic arteries affords better long-term survival [5] [6] [7] [8] [9] . This evidence has extended to the use in some studies of radial arteries as the second-best conduits after internal thoracic arteries [10, 11] . Most studies, however, have failed to show early survival benefits from arterial grafting. The Arterial Revascularization Trial (ART) recently failed to show any survival benefit even with 2 internal thoracic arteries [mortality rate 8.4% (single) vs 8.7% (bilateral), HR 1.04, 95% CI 0.81-1.32; P = 0.77] in their interim analysis at 5 years [12] . This result may have been due to the high crossover rate of 16% from a bilateral internal thoracic artery to a single internal thoracic artery in an intentionto-treat analysis, an additional 20% of radial arteries in the single internal thoracic artery cohort and unrealistic compliance of over 90% with the guideline-based medical therapy. However, there is an expectation that the 10-year final results will show a significant survival difference if enough patients survive to meet the assumed power of the trial. SV grafts are associated with a failure rate of 10-20% after 1 year and an additional failure rate of 5% for each subsequent year [13] [14] [15] . Early graft failures are ascribed to operative technique (off-pump vs on-pump), harvesting technique (open vs endoscopic), the nature of the grafts and distal vessel quality. Mid-term failures are due to neointimal hyperplasia, and late failure is due to progression of atherosclerotic disease in the conduits. These have substantially improved due to a better understanding of graft physiology, better harvesting techniques, dual antiplatelet agents, statins and control of risk factors such as diabetes, hypertension, hyperlipidaemia and smoking.
More recent randomized controlled trials with protocols for coronary angiography that have compared radial arteries to SVs as second-best conduits have obtained equivocal results for both early and mid-term graft patency and survival [16] [17] [18] . Buxton et al. did not show any significant differences in graft patency between the radial artery and the SV at 6 years in the Radial Artery Patency and Clinical Outcomes (RAPCO) trial. Similarly, the multicentre Radial Artery Patency Study (RAPS) showed no difference in significant graft stenosis of the patent RA grafts and SVGs (8.6% vs 11.7%) at 5 years. The overall burden of graft body disease was higher in SV grafts (P = 0.03) so they were likely to fail faster after 5 years. Two further meta-analyses confirmed these findings [19, 20] .
It has been reasonable to assume that survival benefits of arterial grafts accrue from superior graft patency. Direct correlation studies are almost impossible because they require invasive angiograms, cost more and are less practical. Large, nonrandomized angiographic studies comparing the patency of grafts are mostly limited to patients with recurrent angina and are short term. In addition, survival rates cannot be determined from the results of these studies. On the other hand, survival data, even from well-organized registries such as the American College of Cardiology Foundation-Society of Thoracic Surgeons Database Collaboration on the Comparative Effectiveness of Revascularization Strategies (ASCERT), do not include angiographic evidence of patency and do not differentiate between cardiac and non-cardiac deaths. In one of the largest studies to date, Sabik et al. [21] studied symptom-directed graft patency in 8.6% of the 50 278 patients with primary CABG over a 27-year period from 1972 to 1999 at the Cleveland Clinic, which corresponds to just 0.32% per year for the total number of CABGs performed over this period. There are also factors related to the further progression and regression of atherosclerotic disease in distal native vessels with arterial grafts [22, 23] . The higher redox state and the increased production of nitric oxide in internal mammary arteries protect against graft occlusion and progression of distal native disease. These effects have not been shown to be as pronounced for radial arteries and are absent in veins.
If survival were related to graft patency alone, these survival differences between arterial and venous grafts should start to emerge from the first year. There is, however, an incongruity between the patency rates and the survival rates of venous and arterial conduits during the early years. This discrepancy corrects itself during the mid-term and late period (5-7 years) with clearcut differences emerging between the 2 conduits. One must ask, are there factors other than graft patency that influence the hard end-points such as survival?
In the Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures (PREVENT) IV study, 12-18 months after CABG, 42.8% of patients had vein graft failure (defined as angiographically evident stenosis of >75%) and 25.2% of all vein grafts had failed [24, 25] . Longer duration of the surgical procedure, endoscopic vein harvesting, poor target artery quality and postoperative use of clopidogrel or ticlopidine were associated with vein graft failures.
After the introduction of angiographic protocols, there was a markedly higher rate of death, myocardial infarction or revascularization within 14 days of angiography among patients who had vein graft failure compared with those who did not (adjusted HR 5.52, 95% CI 3.55-8.56; P < 0.001). Among those who did not need revascularization, the composite end-point of death, myocardial infarction or revascularization occurred more frequently among patients who had any vein graft failure compared with those who had none (adjusted HR 1.58, 95% CI 1.21-2.06; P = 0.008).
The basis for revascularization remains the oculostenotic assessment of lesions with no functional testing for the burden of ischaemia. In the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) study, of all patients with angiographic 3-vessel disease, 86% had only 2 or even fewer functionally significant diseased coronary arteries [24, 25] . Early graft loss to these territories is unlikely to impact survival and could partly explain the discrepancy between graft patency and survival rates in some studies.
A recent propensity-matched study by Tranbaugh et al. [26] showed overall better RA vs SV survival (HR 0.82, P < 0.001) only in patients aged less than 70 years (HR 0.77, P < 0.001) and no difference in RITA vs SV survival (HR 0.95, P = 0.35) in those older than 70 years. In contrast, there were significant early survival benefits noted in our study in favour of all arterial conduits for all patients aged less than and greater than 70 years (both matched and unmatched). These benefits were evident as early as the second year in propensity-matched data (survival: arterial, 98.16% vs venous, 96.68%; P = 0.025). It was also striking that the divergence of the survival curves accelerated by 4-5 years in unmatched data and as early as 3 years in matched data, possibly due to late failure in the vein grafts. The effects were possibly accentuated after balancing for covariates with propensity matching.
Further, our data show that a single additional arterial graft to the circumflex circulation was enough to improve survival in the propensity-matched data. The addition of more arterial grafts had no further impact on survival in matched and unmatched data. These results from a non-randomized, propensity-matched 'real-world' study are in contrast to the findings from recent randomized trials (ART, the RAPS and the RAPCO study) that have failed to show survival differences between arterial and vein grafts. These discrepancies between trial data and observational studies may be due to deficiencies of methodology and data collection [27] . Other recent randomized studies have shown no evidence of early vein graft failure or accelerated late failure beyond 5 years [28] [29] [30] . Samano et al. [30] showed an SV failure rate of 17% at 16 years, which was comparable to that of the left internal thoracic artery in veins harvested with the no-touch technique. Given the limitations of this study, these results would need further substantiation.
Limitations
This study is retrospective and from a single centre. The results must therefore be viewed with caution, given the small number of cases at risk in the propensity-matched groups. The results fail to differentiate between cardiac and non-cardiac deaths and are limited by a lack of data for major adverse cardiovascular events and repeat revascularizations. The study also lacks functional testing and angiographic correlation between survival and graft patency.
CONCLUSIONS
A second arterial graft to the circumflex circulation significantly improves early and late survival.
